SEC Form 8-K filed by Oaktree Specialty Lending Corporation

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 5, 2025 (March 4, 2025)

 

Oaktree Specialty Lending Corporation

(Exact name of Registrant as specified in its charter)

 

 

 

Registrant’s telephone number, including area code: (213)

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule of the Securities Exchange Act of 1934 this chapter).

☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

On March 4, 2025, Oaktree Specialty Lending Corporation (the “Company”) held its 2025 annual meeting of stockholders (the “Annual Meeting”). Set forth below are the two proposals voted upon by the Company’s stockholders at the Annual Meeting, as described in the Company’s proxy statement filed with the U.S. Securities and Exchange Commission on January 17, 2025, together with the voting results for each proposal. As of January 6, 2025, the record date for the Annual Meeting, 82,245,319 shares of the Company’s common stock were outstanding and entitled to vote.

 The Company’s stockholders elected the following nominee to serve on the Board of Directors of the Company until the 2028 annual meeting of stockholders and until her successor is duly elected and qualifies: Phyllis R. Caldwell. The tabulation of votes was:

 

 The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2025, as set forth below.

 

On March 4, 2025, the Company also held a special meeting of stockholders (the “Special Meeting”). Set forth below is the proposal voted upon by the Company’s stockholders at the Special Meeting, as described in the Company’s proxy statement filed with the U.S. Securities and Exchange Commission on January 10, 2025, together with the voting results for the proposal. As of January 3, 2025, the record date for the Special Meeting, 82,245,319 shares of the Company’s common stock were outstanding and entitled to vote.

 The Company’s stockholders approved a proposal to authorize the Company, with the approval of the Board of Directors, to sell or otherwise issue shares of its common stock at a price below its then current net asset value per share, provided that the number of shares issued does not exceed 25% of its then outstanding common stock, as set forth below.

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.